Ebpay生命医药出版社

  • Ebpay生命

    102912

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.4 Breast Cancer (Dove Med Press)
    • 3.2 Clin Epidemiol
    • 2.6 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.7 Clin Interv Aging
    • 5.1 Drug Des Dev Ther
    • 3.1 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.6 Int J Women's Health
    • 2.9 Neuropsych Dis Treat
    • 2.8 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.2 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 3.0 Diabet Metab Synd Ob
    • 3.2 Psychol Res Behav Ma
    • 3.4 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.0 Risk Manag Healthc Policy
    • 4.1 J Inflamm Res
    • 2.0 Int J Gen Med
    • 3.4 J Hepatocell Carcinoma
    • 3.0 J Asthma Allergy
    • 2.2 Clin Cosmet Investig Dermatol
    • 2.4 J Multidiscip Healthc



    更多详情 >>





    已发表论文

    人体宫颈鳞状细胞癌中自噬相关标志物 Beclin1，LC3 和表皮生长因子受体 (EGFR) 的表达及临床意义

     

    Authors Hu YF, Lei X, Zhang HY, Ma JW, Yang WW, Chen ML, Cui J, Zhao H

    Received 18 April 2015
    Accepted for publication 16 June 2015
    Published 24 August 2015 Volume 2015:8 Pages 2243—2249
    DOI http://dx.doi.org/10.2147/OTT.S86844
    Checked for plagiarism Yes
    Review by Single-blind
    Peer reviewer comments 3
    Editor who approved publication:  Professor Daniele Santini


    Purpose: We aimed to investigate the expression of EGFR and the autophagy-related markers Beclin1 and LC3 in cervical cancer.
    Methods: Beclin1, LC3, and EGFR expression were analyzed in 80 samples of cervical squamous cell carcinoma (SCC), 40 samples of high-grade cervical intraepithelial neoplasia (CIN), and40 samples of normal cervical tissues by immunohistochemistry. The protein expression rates were analyzed with χ     2 and Fisher’s exact tests. Differences in overall survival (OS) were determined using the Kaplan–Meier method and log-rank tests.
    Results: Cervical cancer, high-grade CIN, and normal cervical epithelial cells expressed Beclin1 in 26.2%, 77.5%, and 82.5% of patients, respectively, and expressed LC3 in 28.8%, 70.0%, and 75.0% of patients, respectively. There was a significant difference between cervical SCC and high-grade CIN or normal cervical epithelial cells (P =0.000). Cervical cancer cells, high-grade CIN cells, and normal cervical epithelial cells expressed EGFR in 68.8%, 62.5%, and 12.5% of patients, respectively. There was a significant difference between cervical SCC or high-grade CIN and normal cervical epithelial cells (P =0.000). No significant association between Beclin1 or LC3 or EGFR expression and various clinicopathological parameters was observed in cervical SCC. There was no significant correlation between Beclin1, LC3, EGFR expression, and 5-year OS rates of cervical SCC patients. Beclin1- or LC3-negativity with EGFR-positivity in cervical SCC was associated with a higher Federation International of Gynecology and Obstetrics (FIGO) stage (P =0.011 and P =0.013, respectively) and pelvic lymph node metastasis (P =0.036 and P =0.092, respectively). The 5-year OS rates did not significantly differ between Beclin1- or LC3-positive and -negative patients with positive EGFR.
    Conclusion: Autophagy was downregulated and EGFR was upregulated in cervical SCC. Autophagy downregulation combined with EGFR upregulation promotes the progression of cervical SCC.
    Keywords: autophagy, Beclin1, LC3, EGFR, cervical squamous cell carcinoma, immuno­histochemistry


    Download Article[PDF]